Integral Diagnostics
Integral Diagnostics is a leading provider of medical imaging services in Australia and New Zealand, offering a comprehensive range of diagnostic imaging services. The company is known for its advanced technology and skilled radiologists, ensuring high-quality patient care and accurate diagnostics.
Short position
Integral Diagnostics (ASX:IDX) has 1.78% of its shares on issue reported as short positions as of 5 Oct 2026, or about 6,666,607 shares. Over the past 30 days that figure has fallen 0.38 percentage points, and over 90 days it has risen 0.40 percentage points. Its highest recorded short interest was 5.56% in October 2024. IDX is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Integral Diagnostics (IDX) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $788.6Mvs $627.2M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- NPAT
- $21.9Mvs $4.7M (FY25)
- Yahoo Finance, as at 29 Sep 2026
- EPS (diluted)
- $0.058vs $0.016 (FY25)
- Yahoo Finance, as at 29 Sep 2026
- Rev YoY
- +25.7%FY
- EPS YoY
- +262.5%TTM
Key ratios
Year to 30 Jun 2026 (FY); balance sheet at 30 Jun 2026; prices to 9 Oct 2026
- Gross margin
- 95.4%
- Operating margin
- 8.7%
- Net margin
- 2.8%
- FCF margin
- 5.8%
- ROE
- 3.2%
- ROA
- 1.5%
- FCF conversion
- 2.08×
- Net debt (excl. leases)
- $290.5M
- Net debt / EBITDA
- 2.3×
- Current ratio
- 0.7×
- Interest cover
- 3.4×
- Cash dividends paid / net profit
- 118.2%
- Market cap
- $800.8M
- P/E
- 37.1×
- P/B
- 1.2×
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 29 Sep 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $788.6M | $627.2M | $469.7M | $440.1M |
| Gross profit | $752.7M | $599.1M | $446.8M | $419.1M |
| Operating income | $68.4M | $57.5M | $42.2M | $39.1M |
| EBITDA | $126.6M | $87.7M | $6.7M | $92.5M |
| EBIT | $52.5M | $31.2M | −$40.1M | $49.0M |
| Interest expense | $20.4M | $19.5M | $17.0M | $18.4M |
| Pretax income | $32.1M | $11.7M | −$57.1M | $30.6M |
| Tax | $10.1M | $6.8M | $3.6M | $5.6M |
| NPAT | $21.9M | $4.7M | −$60.7M | $25.0M |
| Net interest income | −$32.3M | −$27.8M | −$21.7M | −$17.9M |
| EPS basic | $0.059 | $0.016 | −$0.26 | $0.11 |
| EPS diluted | $0.058 | $0.016 | −$0.26 | $0.11 |
| Shares | 372.5M | 372.2M | 233.9M | 233.0M |
Financial reports
The company's own filings, newest first
- FY26 Annual ReportAnnual Report25 Aug 2026via asx_announcements
- FY26 Full Year Results AnnouncementFull Year Results25 Aug 2026via asx_announcements
- FY26 Half Year Results App4D and Interim ReportHalf Year Results24 Feb 2026via asx_announcements
- FY26 Half Year Results Media ReleaseHalf Year Results24 Feb 2026via asx_announcements
- FY26 Half Year Results Investor PresentationHalf Year Results24 Feb 2026via asx_announcements
- FY26 Half Year Results Release Date and Conference CallHalf Year Results15 Jan 2026via asx_announcements
- GRI Index 2025Financial Report31 Dec 2025via crawler
- Download Career BrochureFinancial Report31 Dec 2025via crawler
- PKF Assurance 2025Financial Report31 Dec 2025via crawler
- Appendix 4E and FY25 Annual ReportAnnual Results26 Aug 2025via asx_announcements
Showing 10 of 26 reports